Quantcast
Last updated on April 23, 2014 at 1:22 EDT

Latest stem cell therapy Stories

2011-11-14 22:52:41

A research network led by a Mayo Clinic physician found that stem cells obtained from bone marrow delivered two to three weeks after a person has a heart attack did not improve heart function. This is the first study to systematically examine the timing and method of stem cell delivery and provides vital information for the field of cell therapy. The results were presented this morning at the 2011 Scientific Sessions of the American Heart Association Meeting in Orlando, Fla. They also will...

2011-09-07 13:58:25

Neurosurgery researchers at UC Davis Health System have used a new, leading-edge stem cell therapy to promote the growth of bone tissue following the removal of cervical discs -- the cushions between the bones in the neck -- to relieve chronic, debilitating pain. The procedure was performed by associate professors of neurosurgery Kee Kim and Rudolph Schrot. It used bone marrow-derived adult stem cells to promote the growth of the bone tissue essential for spinal fusion following surgery,...

2011-07-29 16:00:00

NATICK, Mass., July 29, 2011 /PRNewswire/ -- RegenoCELL Therapeutics, Inc. (OTCBB: RCLL) , a leader in adult stem cell therapy, is pleased to announce it is planning to open another state of the art facility in Panama for patients to be treated for congestive heart failure and peripheral artery disease with its autologous stem cell therapy. The Company's treatment for congestive heart failure when cleared for importation into Panama will be administered at the Hospital Sante Fe. Panama...

2011-07-19 13:20:54

Scientists at the Keck School of Medicine of USC grow brain cells from skin Oncogenes are generally thought to be genes that, when mutated, change healthy cells into cancerous tumor cells. Scientists at the Keck School of Medicine of the University of Southern California (USC) have proven that those genes also can change normal cells into stem-like cells, paving the way to a safer and more practical approach to treating diseases like multiple sclerosis and cancer with stem cell therapy. "The...

2011-07-18 12:38:00

NATICK, Mass., July 18, 2011 /PRNewswire/ -- RegenoCELL Therapeutics, Inc. (OTCBB: RCLL) -announced that it will be featured in an upcoming segment of Profiles with Terry Bradshaw. Profiles follows fascinating business stories to give viewers first-hand insights from entrepreneurs of various industries. As part of the Company's segment, viewers will be educated about the unique individualized medicine and technology the Company is utilizing as a treatment for congestive heart failure and...

2011-07-12 16:00:00

NATICK, Mass., July 12, 2011 /PRNewswire/ -- RegenoCELL Therapeutics, Inc. (OTCBB: RCLL) - gave a second half update. James F. Mongiardo, Chief Executive Officer, reported that plans are being made for the conduct of clinical trials in the United States and Europe for its stem cell therapy. Simultaneous with these efforts, the company's foreign subsidiary, Regenocell, Ltd., reported that it expects to begin marketing the company's stem cell product for the treatment of congestive heart...

2011-07-08 16:00:00

NATICK, Mass., July 8, 2011 /PRNewswire/ -- RegenoCELL Therapeutics, Inc. (OTCBB: RCLL) , a leader in adult stem cell therapy, is pleased to announce the opening of another state of the art facility in Greece for patients to be treated for congestive heart failure and peripheral artery disease with its autologous stem cell therapy. The Company's treatment for congestive heart failure is administered at the Metropolitan Hospital in Athens, which is part of the PERSEUS Heath Care Group....

2011-06-09 06:56:00

NATICK, Mass., June 9, 2011 /PRNewswire/ -- RegenoCELL Therapeutics, Inc. (OTCBB: RCLL), a leader in adult stem cell therapy, today reported on the progress of one of the patients treated with adult stem cells. Seventy-four year old George, from Illinois, had his first bypass in 1980. He had a 2nd bypass in 1990 and a third in 2004. About a year and a half ago, his physicians told him that he had severe blockage of his arteries and a very low ejection fraction. "My dad's a fighter and...

2011-04-12 15:19:00

Grants made possible through donations from real estate pioneer A. Alfred Taubman and other donors to the A. Alfred Taubman Medical Research Institute ANN ARBOR, Mich., April 12, 2011 /PRNewswire-USNewswire/ -- The second round of Taubman Scholars has been announced at the University of Michigan's A. Alfred Taubman Medical Research Institute. Seven leading U-M clinician-scientists will receive the prestigious grants, which will give them unprecedented freedom to conduct "high risk,...

2011-01-19 14:43:39

Results illustrate potential value of Athersys' adult stem cell therapy to reduce damage and promote neuronal regrowth Case Western Reserve University School of Medicine and Athersys, Inc. (NASDAQ: ATHX) announced a joint scientific study on spinal cord injury will be published today in the January issue of the Journal of Neuroscience. The study, by leading researchers from the Department of Neurosciences at the School of Medicine and scientists at Athersys, presents data supporting the...